Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides.
about
Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathyMitochondrial oxidative stress in aging and healthspanPresent and future pharmacotherapeutic agents in heart failure: an evolving paradigmQuality control systems in cardiac agingTargeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesisFirst-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergeticsSerendipity and the discovery of novel compounds that restore mitochondrial plasticityMitochondrial dysfunction in cardiac agingPost-translational modifications of the cardiac proteome in diabetes and heart failurePrognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory SupportCardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling.Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases.Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.Proteomic analysis of short-term preload-induced eccentric cardiac hypertrophy.Pharmacological Strategies to Retard Cardiovascular AgingBendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart.Quantitative Non-canonical Amino Acid Tagging (QuaNCAT) Proteomics Identifies Distinct Patterns of Protein Synthesis Rapidly Induced by Hypertrophic Agents in Cardiomyocytes, Revealing New Aspects of Metabolic Remodeling.Protein kinetic signatures of the remodeling heart following isoproterenol stimulation.Expert consensus document: Mitochondrial function as a therapeutic target in heart failurePathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?The Aging HeartRole of microRNA in metabolic shift during heart failure.Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure.Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure.Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia.Mitochondrial-targeted catalase is good for the old mouse proteome, but not for the young: 'reverse' antagonistic pleiotropy?Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death.Mitochondrial reactive oxygen species production and respiratory complex activity in rats with pressure overload-induced heart failure.Mitochondria Associated MicroRNA Expression Profiling of Heart Failure.Protein kinase D activation induces mitochondrial fragmentation and dysfunction in cardiomyocytes.The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.
P2860
Q27006945-826AD2D0-8956-445A-8E6D-70152EBE98AEQ27025099-4B260596-C82B-434F-8CDA-37282C4FDCD2Q28077186-566313A3-ABFF-4069-BD5E-9B55D9EDD954Q28084341-4A202AA2-66A7-4132-BA6C-B66D211F37CFQ28383442-2F37BA11-83A1-4400-A469-39E8A53B5D15Q28383451-7CAB8912-4D9A-4933-8796-0250EBBFA7FCQ28384256-35624982-6AFF-47BE-AAE1-FB36F23D3EB2Q28389063-825B974C-9B0F-4120-B205-BC4DBCCE8F6DQ33361067-D6471E65-D560-47EA-B6BB-9A192F00DE2EQ33677357-2C9AA9B5-00E8-4865-8089-539AADF05DDCQ34404106-4CA6630D-31F6-4269-9E63-AFC27CA6038EQ35148462-B70B7EC5-BB5E-4CD0-BEBC-9471C33F1871Q35645530-76A4C89A-E60E-4EE9-9A2D-FF4E84850EECQ36550830-BFD7A48F-CE13-473C-BF23-B35BF468FFD2Q36945254-1A0A659B-DD22-4A87-B2E8-F56568B84B33Q36972415-85E8A86F-0C20-4B1E-A08E-3AB3D2DBCCA0Q37151412-B2873C3C-2DBA-4952-9999-6690E3402C5FQ37318949-42509978-7E27-4695-AC08-1693DDDA3961Q37679993-4297E408-605B-4B78-A654-D62580E14F4AQ37699474-6F371390-C725-41DB-BDA0-48B9BC9D6994Q38165049-037466A3-27EB-4632-A9EE-208DEE2759F9Q38578328-8923D0D7-998F-47D2-B6C5-A94FA9282947Q38981243-A521B208-C3C2-4529-AB17-A462E444DABBQ39401767-C44A58A1-B6C5-4273-ABC4-275C438C532AQ41297700-B25F5145-3779-4FF3-A755-4E445D617D99Q41548664-E6381B54-B35F-4B16-8A5C-E81F53FA70D3Q42154295-594FAC6A-07C2-41ED-83AA-8A3C57F08C6BQ46539324-594328F5-CB9A-4B40-9FEF-2003508019C4Q46876398-88B386A5-74E3-4DEB-8C24-10BC44921A46Q47152797-96A53540-3836-49EA-B671-C93F923497BEQ47219342-1C4FA5CD-0FA0-4F56-AB3C-F95AF5D0F909Q51210259-F6E43134-157B-4112-81CB-E9E2DF9580D9
P2860
Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Global proteomics and pathway ...... tochondrial-targeted peptides.
@en
Global proteomics and pathway ...... tochondrial-targeted peptides.
@nl
type
label
Global proteomics and pathway ...... tochondrial-targeted peptides.
@en
Global proteomics and pathway ...... tochondrial-targeted peptides.
@nl
prefLabel
Global proteomics and pathway ...... tochondrial-targeted peptides.
@en
Global proteomics and pathway ...... tochondrial-targeted peptides.
@nl
P2093
P2860
P50
P1476
Global proteomics and pathway ...... tochondrial-targeted peptides.
@en
P2093
David A Crispin
Edward J Hsieh
Hazel H Szeto
Lauren Tsai
Lorena G Menendez
Nicholas J Shulman
Peter S Rabinovitch
Richard P Beyer
P2860
P304
P356
10.1161/CIRCHEARTFAILURE.113.000406
P577
2013-08-09T00:00:00Z